nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLCO2B1—Erlotinib—kidney cancer	0.105	0.223	CbGbCtD
Dinoprostone—SLCO1B1—Pazopanib—kidney cancer	0.0764	0.162	CbGbCtD
Dinoprostone—CYP19A1—Paclitaxel—kidney cancer	0.0676	0.143	CbGbCtD
Dinoprostone—ABCC4—Sorafenib—kidney cancer	0.0654	0.139	CbGbCtD
Dinoprostone—ABCC4—Sunitinib—kidney cancer	0.053	0.112	CbGbCtD
Dinoprostone—SLC22A2—Vinblastine—kidney cancer	0.0471	0.0997	CbGbCtD
Dinoprostone—CYP1A2—Pazopanib—kidney cancer	0.025	0.053	CbGbCtD
Dinoprostone—CYP1A2—Erlotinib—kidney cancer	0.0178	0.0378	CbGbCtD
Dinoprostone—CYP1A2—Sorafenib—kidney cancer	0.0145	0.0307	CbGbCtD
Dinoprostone—HPGDS—urine—kidney cancer	0.00862	0.0614	CbGeAlD
Dinoprostone—SLCO3A1—nephron—kidney cancer	0.00774	0.055	CbGeAlD
Dinoprostone—SLC22A2—nephron—kidney cancer	0.00742	0.0528	CbGeAlD
Dinoprostone—SLC22A8—nephron—kidney cancer	0.00482	0.0343	CbGeAlD
Dinoprostone—SLC22A8—urine—kidney cancer	0.00387	0.0275	CbGeAlD
Dinoprostone—SLC51B—cortex of kidney—kidney cancer	0.00372	0.0265	CbGeAlD
Dinoprostone—PTGER4—renal system—kidney cancer	0.00288	0.0205	CbGeAlD
Dinoprostone—PTGER4—kidney—kidney cancer	0.00279	0.0198	CbGeAlD
Dinoprostone—PTGER1—renal system—kidney cancer	0.00278	0.0198	CbGeAlD
Dinoprostone—PTGER4—cortex of kidney—kidney cancer	0.00271	0.0193	CbGeAlD
Dinoprostone—PTGER1—kidney—kidney cancer	0.00269	0.0191	CbGeAlD
Dinoprostone—SLC51A—cortex of kidney—kidney cancer	0.00267	0.019	CbGeAlD
Dinoprostone—CYP1A2—urine—kidney cancer	0.00265	0.0188	CbGeAlD
Dinoprostone—SLC51A—gonad—kidney cancer	0.00254	0.0181	CbGeAlD
Dinoprostone—PTGER3—renal system—kidney cancer	0.00244	0.0174	CbGeAlD
Dinoprostone—PTGER3—kidney—kidney cancer	0.00236	0.0168	CbGeAlD
Dinoprostone—HPGDS—renal system—kidney cancer	0.00211	0.015	CbGeAlD
Dinoprostone—HPGDS—kidney—kidney cancer	0.00204	0.0145	CbGeAlD
Dinoprostone—HPGDS—gonad—kidney cancer	0.00189	0.0135	CbGeAlD
Dinoprostone—SLC22A11—nephron tubule—kidney cancer	0.00184	0.0131	CbGeAlD
Dinoprostone—SLC22A6—nephron tubule—kidney cancer	0.00174	0.0124	CbGeAlD
Dinoprostone—SLCO1C1—renal system—kidney cancer	0.00173	0.0123	CbGeAlD
Dinoprostone—PTGIR—renal system—kidney cancer	0.00172	0.0122	CbGeAlD
Dinoprostone—SLC22A11—renal system—kidney cancer	0.00168	0.0119	CbGeAlD
Dinoprostone—SLCO1C1—kidney—kidney cancer	0.00167	0.0119	CbGeAlD
Dinoprostone—PTGIR—kidney—kidney cancer	0.00166	0.0118	CbGeAlD
Dinoprostone—SLCO2A1—nephron tubule—kidney cancer	0.00165	0.0118	CbGeAlD
Dinoprostone—SLC22A7—renal system—kidney cancer	0.00164	0.0116	CbGeAlD
Dinoprostone—SLC22A11—kidney—kidney cancer	0.00162	0.0115	CbGeAlD
Dinoprostone—SLC22A2—nephron tubule—kidney cancer	0.0016	0.0114	CbGeAlD
Dinoprostone—SLC22A7—kidney—kidney cancer	0.00158	0.0113	CbGeAlD
Dinoprostone—SLC22A11—cortex of kidney—kidney cancer	0.00158	0.0112	CbGeAlD
Dinoprostone—PTGIR—gonad—kidney cancer	0.00154	0.011	CbGeAlD
Dinoprostone—SLC22A7—cortex of kidney—kidney cancer	0.00154	0.011	CbGeAlD
Dinoprostone—SLCO4A1—nephron tubule—kidney cancer	0.00152	0.0108	CbGeAlD
Dinoprostone—SLCO3A1—renal system—kidney cancer	0.00152	0.0108	CbGeAlD
Dinoprostone—ABCC5—nephron tubule—kidney cancer	0.00151	0.0108	CbGeAlD
Dinoprostone—SLCO2A1—renal system—kidney cancer	0.0015	0.0107	CbGeAlD
Dinoprostone—SLC22A6—cortex of kidney—kidney cancer	0.00149	0.0106	CbGeAlD
Dinoprostone—SLCO3A1—kidney—kidney cancer	0.00147	0.0104	CbGeAlD
Dinoprostone—SLC22A2—renal system—kidney cancer	0.00146	0.0104	CbGeAlD
Dinoprostone—SLCO2A1—kidney—kidney cancer	0.00145	0.0103	CbGeAlD
Dinoprostone—SLCO3A1—cortex of kidney—kidney cancer	0.00143	0.0102	CbGeAlD
Dinoprostone—SLCO2A1—cortex of kidney—kidney cancer	0.00142	0.0101	CbGeAlD
Dinoprostone—SLC22A2—kidney—kidney cancer	0.00141	0.01	CbGeAlD
Dinoprostone—SLCO4A1—renal system—kidney cancer	0.00138	0.00984	CbGeAlD
Dinoprostone—SLC22A2—cortex of kidney—kidney cancer	0.00137	0.00975	CbGeAlD
Dinoprostone—SLCO3A1—gonad—kidney cancer	0.00136	0.00968	CbGeAlD
Dinoprostone—SLCO3A1—cardiac atrium—kidney cancer	0.00136	0.00967	CbGeAlD
Dinoprostone—SLCO2A1—cardiac atrium—kidney cancer	0.00135	0.00958	CbGeAlD
Dinoprostone—SLCO4A1—kidney—kidney cancer	0.00134	0.00951	CbGeAlD
Dinoprostone—CYP11A1—gonad—kidney cancer	0.00133	0.00949	CbGeAlD
Dinoprostone—SLCO4A1—cortex of kidney—kidney cancer	0.0013	0.00926	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS1—kidney cancer	0.00128	0.636	CrCbGaD
Dinoprostone—SLCO4A1—cardiac atrium—kidney cancer	0.00124	0.00881	CbGeAlD
Dinoprostone—ABCC5—cardiac atrium—kidney cancer	0.00123	0.00876	CbGeAlD
Dinoprostone—SLCO1B1—renal system—kidney cancer	0.00122	0.00866	CbGeAlD
Dinoprostone—SLCO1B1—kidney—kidney cancer	0.00118	0.00837	CbGeAlD
Dinoprostone—SLCO2B1—renal system—kidney cancer	0.00108	0.00766	CbGeAlD
Dinoprostone—ABCC4—nephron tubule—kidney cancer	0.00105	0.00746	CbGeAlD
Dinoprostone—SLCO2B1—kidney—kidney cancer	0.00104	0.0074	CbGeAlD
Dinoprostone—SLC22A8—nephron tubule—kidney cancer	0.00104	0.0074	CbGeAlD
Dinoprostone—SLC22A1—renal system—kidney cancer	0.00103	0.00732	CbGeAlD
Dinoprostone—SLC22A1—kidney—kidney cancer	0.000994	0.00707	CbGeAlD
Dinoprostone—SLCO1A2—renal system—kidney cancer	0.00099	0.00705	CbGeAlD
Dinoprostone—SLCO1A2—kidney—kidney cancer	0.000958	0.00681	CbGeAlD
Dinoprostone—ABCC4—renal system—kidney cancer	0.000953	0.00678	CbGeAlD
Dinoprostone—SLC22A8—renal system—kidney cancer	0.000946	0.00673	CbGeAlD
Dinoprostone—ABCC4—kidney—kidney cancer	0.000921	0.00656	CbGeAlD
Dinoprostone—SLC22A8—kidney—kidney cancer	0.000914	0.0065	CbGeAlD
Dinoprostone—ABCC4—cortex of kidney—kidney cancer	0.000897	0.00638	CbGeAlD
Dinoprostone—SLC22A8—cortex of kidney—kidney cancer	0.00089	0.00633	CbGeAlD
Dinoprostone—CYP19A1—gonad—kidney cancer	0.000867	0.00617	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—kidney cancer	0.000729	0.364	CrCbGaD
Dinoprostone—CYP1A2—renal system—kidney cancer	0.000648	0.00461	CbGeAlD
Dinoprostone—Gastrointestinal pain—Vinblastine—kidney cancer	0.000351	0.00171	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Everolimus—kidney cancer	0.000349	0.00171	CcSEcCtD
Dinoprostone—Asthma—Capecitabine—kidney cancer	0.000346	0.00169	CcSEcCtD
Dinoprostone—Vomiting—Pazopanib—kidney cancer	0.000344	0.00168	CcSEcCtD
Dinoprostone—Rash—Pazopanib—kidney cancer	0.000341	0.00167	CcSEcCtD
Dinoprostone—Nausea—Temsirolimus—kidney cancer	0.000341	0.00167	CcSEcCtD
Dinoprostone—Dermatitis—Pazopanib—kidney cancer	0.000341	0.00166	CcSEcCtD
Dinoprostone—Bronchospasm—Capecitabine—kidney cancer	0.00034	0.00166	CcSEcCtD
Dinoprostone—Back pain—Gemcitabine—kidney cancer	0.000339	0.00166	CcSEcCtD
Dinoprostone—Abdominal pain—Vinblastine—kidney cancer	0.000339	0.00166	CcSEcCtD
Dinoprostone—Headache—Pazopanib—kidney cancer	0.000339	0.00166	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000338	0.00165	CcSEcCtD
Dinoprostone—Body temperature increased—Everolimus—kidney cancer	0.000338	0.00165	CcSEcCtD
Dinoprostone—Abdominal pain—Everolimus—kidney cancer	0.000338	0.00165	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Erlotinib—kidney cancer	0.000337	0.00165	CcSEcCtD
Dinoprostone—Sweating increased—Capecitabine—kidney cancer	0.000337	0.00165	CcSEcCtD
Dinoprostone—Vaginal infection—Doxorubicin—kidney cancer	0.000336	0.00164	CcSEcCtD
Dinoprostone—Pharyngitis—Paclitaxel—kidney cancer	0.000335	0.00164	CcSEcCtD
Dinoprostone—Dyspnoea—Sorafenib—kidney cancer	0.000331	0.00161	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000327	0.00159	CcSEcCtD
Dinoprostone—Body temperature increased—Erlotinib—kidney cancer	0.000326	0.00159	CcSEcCtD
Dinoprostone—Abdominal pain—Erlotinib—kidney cancer	0.000326	0.00159	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000325	0.00159	CcSEcCtD
Dinoprostone—Nausea—Pazopanib—kidney cancer	0.000321	0.00157	CcSEcCtD
Dinoprostone—Paraesthesia—Sunitinib—kidney cancer	0.000321	0.00156	CcSEcCtD
Dinoprostone—Hypertension—Vincristine—kidney cancer	0.000319	0.00156	CcSEcCtD
Dinoprostone—Dyspnoea—Sunitinib—kidney cancer	0.000318	0.00155	CcSEcCtD
Dinoprostone—Pain—Sorafenib—kidney cancer	0.000317	0.00155	CcSEcCtD
Dinoprostone—Hypersensitivity—Vinblastine—kidney cancer	0.000316	0.00154	CcSEcCtD
Dinoprostone—Myalgia—Vincristine—kidney cancer	0.000315	0.00154	CcSEcCtD
Dinoprostone—Hypersensitivity—Everolimus—kidney cancer	0.000315	0.00154	CcSEcCtD
Dinoprostone—Flushing—Paclitaxel—kidney cancer	0.000313	0.00153	CcSEcCtD
Dinoprostone—Hypertonia—Doxorubicin—kidney cancer	0.000312	0.00152	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000308	0.0015	CcSEcCtD
Dinoprostone—Asthenia—Vinblastine—kidney cancer	0.000308	0.0015	CcSEcCtD
Dinoprostone—Asthenia—Everolimus—kidney cancer	0.000307	0.0015	CcSEcCtD
Dinoprostone—Cough—Gemcitabine—kidney cancer	0.000306	0.0015	CcSEcCtD
Dinoprostone—Angiopathy—Paclitaxel—kidney cancer	0.000306	0.0015	CcSEcCtD
Dinoprostone—Pain—Sunitinib—kidney cancer	0.000305	0.00149	CcSEcCtD
Dinoprostone—Immune system disorder—Paclitaxel—kidney cancer	0.000305	0.00149	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Capecitabine—kidney cancer	0.000304	0.00148	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000303	0.00148	CcSEcCtD
Dinoprostone—Hypertension—Gemcitabine—kidney cancer	0.000303	0.00148	CcSEcCtD
Dinoprostone—Chills—Paclitaxel—kidney cancer	0.000303	0.00148	CcSEcCtD
Dinoprostone—Myocardial infarction—Capecitabine—kidney cancer	0.000302	0.00148	CcSEcCtD
Dinoprostone—Anaphylactic shock—Vincristine—kidney cancer	0.000302	0.00147	CcSEcCtD
Dinoprostone—Arrhythmia—Paclitaxel—kidney cancer	0.000302	0.00147	CcSEcCtD
Dinoprostone—Myalgia—Gemcitabine—kidney cancer	0.000299	0.00146	CcSEcCtD
Dinoprostone—Chest pain—Gemcitabine—kidney cancer	0.000299	0.00146	CcSEcCtD
Dinoprostone—Arthralgia—Gemcitabine—kidney cancer	0.000299	0.00146	CcSEcCtD
Dinoprostone—Asthenia—Erlotinib—kidney cancer	0.000296	0.00144	CcSEcCtD
Dinoprostone—Diarrhoea—Vinblastine—kidney cancer	0.000294	0.00143	CcSEcCtD
Dinoprostone—Body temperature increased—Sorafenib—kidney cancer	0.000293	0.00143	CcSEcCtD
Dinoprostone—Abdominal pain—Sorafenib—kidney cancer	0.000293	0.00143	CcSEcCtD
Dinoprostone—Diarrhoea—Everolimus—kidney cancer	0.000292	0.00143	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000292	0.00142	CcSEcCtD
Dinoprostone—Hyperhidrosis—Vincristine—kidney cancer	0.000292	0.00142	CcSEcCtD
Dinoprostone—Pain—Dactinomycin—kidney cancer	0.000289	0.00141	CcSEcCtD
Dinoprostone—Tension—Paclitaxel—kidney cancer	0.000288	0.00141	CcSEcCtD
Dinoprostone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000286	0.0014	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—kidney cancer	0.000286	0.0014	CcSEcCtD
Dinoprostone—Back pain—Paclitaxel—kidney cancer	0.000284	0.00139	CcSEcCtD
Dinoprostone—Dizziness—Vinblastine—kidney cancer	0.000284	0.00138	CcSEcCtD
Dinoprostone—Dizziness—Everolimus—kidney cancer	0.000283	0.00138	CcSEcCtD
Dinoprostone—Muscle spasms—Paclitaxel—kidney cancer	0.000282	0.00138	CcSEcCtD
Dinoprostone—Abdominal pain—Sunitinib—kidney cancer	0.000282	0.00138	CcSEcCtD
Dinoprostone—Body temperature increased—Sunitinib—kidney cancer	0.000282	0.00138	CcSEcCtD
Dinoprostone—Diarrhoea—Erlotinib—kidney cancer	0.000282	0.00138	CcSEcCtD
Dinoprostone—Hypotension—Vincristine—kidney cancer	0.000282	0.00138	CcSEcCtD
Dinoprostone—Vision blurred—Paclitaxel—kidney cancer	0.000277	0.00135	CcSEcCtD
Dinoprostone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000277	0.00135	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000276	0.00135	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—kidney cancer	0.000276	0.00135	CcSEcCtD
Dinoprostone—Tremor—Paclitaxel—kidney cancer	0.000275	0.00134	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000275	0.00134	CcSEcCtD
Dinoprostone—Pharyngitis—Capecitabine—kidney cancer	0.000275	0.00134	CcSEcCtD
Dinoprostone—Menopausal symptoms—Doxorubicin—kidney cancer	0.000274	0.00134	CcSEcCtD
Dinoprostone—Hypersensitivity—Sorafenib—kidney cancer	0.000273	0.00133	CcSEcCtD
Dinoprostone—Vomiting—Vinblastine—kidney cancer	0.000273	0.00133	CcSEcCtD
Dinoprostone—Dizziness—Erlotinib—kidney cancer	0.000273	0.00133	CcSEcCtD
Dinoprostone—Vomiting—Everolimus—kidney cancer	0.000272	0.00133	CcSEcCtD
Dinoprostone—Paraesthesia—Vincristine—kidney cancer	0.000271	0.00132	CcSEcCtD
Dinoprostone—Rash—Everolimus—kidney cancer	0.000269	0.00132	CcSEcCtD
Dinoprostone—Dermatitis—Everolimus—kidney cancer	0.000269	0.00131	CcSEcCtD
Dinoprostone—Headache—Vinblastine—kidney cancer	0.000269	0.00131	CcSEcCtD
Dinoprostone—Headache—Everolimus—kidney cancer	0.000268	0.00131	CcSEcCtD
Dinoprostone—Hypotension—Gemcitabine—kidney cancer	0.000268	0.00131	CcSEcCtD
Dinoprostone—Abdominal pain—Dactinomycin—kidney cancer	0.000267	0.0013	CcSEcCtD
Dinoprostone—Body temperature increased—Dactinomycin—kidney cancer	0.000267	0.0013	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000267	0.0013	CcSEcCtD
Dinoprostone—Asthenia—Sorafenib—kidney cancer	0.000266	0.0013	CcSEcCtD
Dinoprostone—Syncope—Paclitaxel—kidney cancer	0.000263	0.00129	CcSEcCtD
Dinoprostone—Hypersensitivity—Sunitinib—kidney cancer	0.000263	0.00128	CcSEcCtD
Dinoprostone—Vomiting—Erlotinib—kidney cancer	0.000262	0.00128	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000261	0.00127	CcSEcCtD
Dinoprostone—Rash—Erlotinib—kidney cancer	0.00026	0.00127	CcSEcCtD
Dinoprostone—Dermatitis—Erlotinib—kidney cancer	0.00026	0.00127	CcSEcCtD
Dinoprostone—Headache—Erlotinib—kidney cancer	0.000258	0.00126	CcSEcCtD
Dinoprostone—Loss of consciousness—Paclitaxel—kidney cancer	0.000258	0.00126	CcSEcCtD
Dinoprostone—Pain—Vincristine—kidney cancer	0.000258	0.00126	CcSEcCtD
Dinoprostone—Paraesthesia—Gemcitabine—kidney cancer	0.000257	0.00126	CcSEcCtD
Dinoprostone—Flushing—Capecitabine—kidney cancer	0.000257	0.00125	CcSEcCtD
Dinoprostone—Cough—Paclitaxel—kidney cancer	0.000256	0.00125	CcSEcCtD
Dinoprostone—Asthenia—Sunitinib—kidney cancer	0.000256	0.00125	CcSEcCtD
Dinoprostone—Dyspnoea—Gemcitabine—kidney cancer	0.000255	0.00125	CcSEcCtD
Dinoprostone—Nausea—Vinblastine—kidney cancer	0.000255	0.00124	CcSEcCtD
Dinoprostone—Nausea—Everolimus—kidney cancer	0.000254	0.00124	CcSEcCtD
Dinoprostone—Diarrhoea—Sorafenib—kidney cancer	0.000254	0.00124	CcSEcCtD
Dinoprostone—Hypertension—Paclitaxel—kidney cancer	0.000254	0.00124	CcSEcCtD
Dinoprostone—Angiopathy—Capecitabine—kidney cancer	0.000251	0.00123	CcSEcCtD
Dinoprostone—Immune system disorder—Capecitabine—kidney cancer	0.00025	0.00122	CcSEcCtD
Dinoprostone—Myalgia—Paclitaxel—kidney cancer	0.00025	0.00122	CcSEcCtD
Dinoprostone—Chest pain—Paclitaxel—kidney cancer	0.00025	0.00122	CcSEcCtD
Dinoprostone—Arthralgia—Paclitaxel—kidney cancer	0.00025	0.00122	CcSEcCtD
Dinoprostone—Hypersensitivity—Dactinomycin—kidney cancer	0.000249	0.00122	CcSEcCtD
Dinoprostone—Chills—Capecitabine—kidney cancer	0.000249	0.00121	CcSEcCtD
Dinoprostone—Arrhythmia—Capecitabine—kidney cancer	0.000247	0.00121	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Vincristine—kidney cancer	0.000247	0.00121	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—kidney cancer	0.000245	0.0012	CcSEcCtD
Dinoprostone—Dizziness—Sorafenib—kidney cancer	0.000245	0.0012	CcSEcCtD
Dinoprostone—Pain—Gemcitabine—kidney cancer	0.000245	0.0012	CcSEcCtD
Dinoprostone—Nausea—Erlotinib—kidney cancer	0.000245	0.0012	CcSEcCtD
Dinoprostone—Diarrhoea—Sunitinib—kidney cancer	0.000244	0.00119	CcSEcCtD
Dinoprostone—Asthenia—Dactinomycin—kidney cancer	0.000242	0.00118	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—kidney cancer	0.00024	0.00117	CcSEcCtD
Dinoprostone—Anaphylactic shock—Paclitaxel—kidney cancer	0.00024	0.00117	CcSEcCtD
Dinoprostone—Abdominal pain—Vincristine—kidney cancer	0.000239	0.00117	CcSEcCtD
Dinoprostone—Body temperature increased—Vincristine—kidney cancer	0.000239	0.00117	CcSEcCtD
Dinoprostone—Dizziness—Sunitinib—kidney cancer	0.000236	0.00115	CcSEcCtD
Dinoprostone—Shock—Paclitaxel—kidney cancer	0.000236	0.00115	CcSEcCtD
Dinoprostone—Vomiting—Sorafenib—kidney cancer	0.000236	0.00115	CcSEcCtD
Dinoprostone—Tachycardia—Paclitaxel—kidney cancer	0.000234	0.00114	CcSEcCtD
Dinoprostone—Rash—Sorafenib—kidney cancer	0.000234	0.00114	CcSEcCtD
Dinoprostone—Dermatitis—Sorafenib—kidney cancer	0.000234	0.00114	CcSEcCtD
Dinoprostone—Back pain—Capecitabine—kidney cancer	0.000233	0.00114	CcSEcCtD
Dinoprostone—Headache—Sorafenib—kidney cancer	0.000232	0.00113	CcSEcCtD
Dinoprostone—Muscle spasms—Capecitabine—kidney cancer	0.000232	0.00113	CcSEcCtD
Dinoprostone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000232	0.00113	CcSEcCtD
Dinoprostone—Diarrhoea—Dactinomycin—kidney cancer	0.000231	0.00113	CcSEcCtD
Dinoprostone—Vision blurred—Capecitabine—kidney cancer	0.000227	0.00111	CcSEcCtD
Dinoprostone—Vomiting—Sunitinib—kidney cancer	0.000227	0.00111	CcSEcCtD
Dinoprostone—Body temperature increased—Gemcitabine—kidney cancer	0.000226	0.00111	CcSEcCtD
Dinoprostone—Tremor—Capecitabine—kidney cancer	0.000226	0.0011	CcSEcCtD
Dinoprostone—Rash—Sunitinib—kidney cancer	0.000225	0.0011	CcSEcCtD
Dinoprostone—Dermatitis—Sunitinib—kidney cancer	0.000225	0.0011	CcSEcCtD
Dinoprostone—Hypotension—Paclitaxel—kidney cancer	0.000224	0.00109	CcSEcCtD
Dinoprostone—Headache—Sunitinib—kidney cancer	0.000224	0.00109	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—kidney cancer	0.000223	0.00109	CcSEcCtD
Dinoprostone—Hypersensitivity—Vincristine—kidney cancer	0.000222	0.00109	CcSEcCtD
Dinoprostone—Nausea—Sorafenib—kidney cancer	0.00022	0.00108	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000218	0.00107	CcSEcCtD
Dinoprostone—Asthenia—Vincristine—kidney cancer	0.000217	0.00106	CcSEcCtD
Dinoprostone—Syncope—Capecitabine—kidney cancer	0.000216	0.00106	CcSEcCtD
Dinoprostone—Paraesthesia—Paclitaxel—kidney cancer	0.000215	0.00105	CcSEcCtD
Dinoprostone—Vomiting—Dactinomycin—kidney cancer	0.000215	0.00105	CcSEcCtD
Dinoprostone—Dyspnoea—Paclitaxel—kidney cancer	0.000214	0.00104	CcSEcCtD
Dinoprostone—Rash—Dactinomycin—kidney cancer	0.000213	0.00104	CcSEcCtD
Dinoprostone—Nausea—Sunitinib—kidney cancer	0.000212	0.00104	CcSEcCtD
Dinoprostone—Loss of consciousness—Capecitabine—kidney cancer	0.000212	0.00103	CcSEcCtD
Dinoprostone—Cough—Capecitabine—kidney cancer	0.00021	0.00103	CcSEcCtD
Dinoprostone—Hypertension—Capecitabine—kidney cancer	0.000208	0.00102	CcSEcCtD
Dinoprostone—Diarrhoea—Vincristine—kidney cancer	0.000207	0.00101	CcSEcCtD
Dinoprostone—Asthenia—Gemcitabine—kidney cancer	0.000205	0.001	CcSEcCtD
Dinoprostone—Arthralgia—Capecitabine—kidney cancer	0.000205	0.001	CcSEcCtD
Dinoprostone—Chest pain—Capecitabine—kidney cancer	0.000205	0.001	CcSEcCtD
Dinoprostone—Myalgia—Capecitabine—kidney cancer	0.000205	0.001	CcSEcCtD
Dinoprostone—Pain—Paclitaxel—kidney cancer	0.000205	0.001	CcSEcCtD
Dinoprostone—Nausea—Dactinomycin—kidney cancer	0.000201	0.00098	CcSEcCtD
Dinoprostone—Dizziness—Vincristine—kidney cancer	0.0002	0.000975	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000196	0.000957	CcSEcCtD
Dinoprostone—Diarrhoea—Gemcitabine—kidney cancer	0.000196	0.000957	CcSEcCtD
Dinoprostone—Shock—Capecitabine—kidney cancer	0.000194	0.000945	CcSEcCtD
Dinoprostone—Tachycardia—Capecitabine—kidney cancer	0.000192	0.000938	CcSEcCtD
Dinoprostone—Vomiting—Vincristine—kidney cancer	0.000192	0.000937	CcSEcCtD
Dinoprostone—Rash—Vincristine—kidney cancer	0.00019	0.000929	CcSEcCtD
Dinoprostone—Hyperhidrosis—Capecitabine—kidney cancer	0.00019	0.000929	CcSEcCtD
Dinoprostone—Dermatitis—Vincristine—kidney cancer	0.00019	0.000928	CcSEcCtD
Dinoprostone—Abdominal pain—Paclitaxel—kidney cancer	0.00019	0.000925	CcSEcCtD
Dinoprostone—Body temperature increased—Paclitaxel—kidney cancer	0.00019	0.000925	CcSEcCtD
Dinoprostone—Headache—Vincristine—kidney cancer	0.000189	0.000923	CcSEcCtD
Dinoprostone—Hypotension—Capecitabine—kidney cancer	0.000184	0.000898	CcSEcCtD
Dinoprostone—Vomiting—Gemcitabine—kidney cancer	0.000182	0.000889	CcSEcCtD
Dinoprostone—Rash—Gemcitabine—kidney cancer	0.000181	0.000882	CcSEcCtD
Dinoprostone—Dermatitis—Gemcitabine—kidney cancer	0.00018	0.000881	CcSEcCtD
Dinoprostone—Headache—Gemcitabine—kidney cancer	0.000179	0.000876	CcSEcCtD
Dinoprostone—Nausea—Vincristine—kidney cancer	0.000179	0.000875	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000179	0.000875	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—kidney cancer	0.000177	0.000865	CcSEcCtD
Dinoprostone—Paraesthesia—Capecitabine—kidney cancer	0.000177	0.000863	CcSEcCtD
Dinoprostone—Hypersensitivity—Paclitaxel—kidney cancer	0.000177	0.000863	CcSEcCtD
Dinoprostone—Dyspnoea—Capecitabine—kidney cancer	0.000175	0.000857	CcSEcCtD
Dinoprostone—Asthenia—Paclitaxel—kidney cancer	0.000172	0.00084	CcSEcCtD
Dinoprostone—Nausea—Gemcitabine—kidney cancer	0.00017	0.000831	CcSEcCtD
Dinoprostone—Pain—Capecitabine—kidney cancer	0.000168	0.000822	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—kidney cancer	0.000166	0.000809	CcSEcCtD
Dinoprostone—Diarrhoea—Paclitaxel—kidney cancer	0.000164	0.000801	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—kidney cancer	0.000162	0.000791	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—kidney cancer	0.000161	0.000787	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000161	0.000786	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—kidney cancer	0.00016	0.000782	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—kidney cancer	0.000159	0.000779	CcSEcCtD
Dinoprostone—Dizziness—Paclitaxel—kidney cancer	0.000159	0.000774	CcSEcCtD
Dinoprostone—Body temperature increased—Capecitabine—kidney cancer	0.000156	0.000759	CcSEcCtD
Dinoprostone—Abdominal pain—Capecitabine—kidney cancer	0.000156	0.000759	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—kidney cancer	0.000153	0.000745	CcSEcCtD
Dinoprostone—Vomiting—Paclitaxel—kidney cancer	0.000152	0.000744	CcSEcCtD
Dinoprostone—Rash—Paclitaxel—kidney cancer	0.000151	0.000738	CcSEcCtD
Dinoprostone—Dermatitis—Paclitaxel—kidney cancer	0.000151	0.000737	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—kidney cancer	0.00015	0.000734	CcSEcCtD
Dinoprostone—Headache—Paclitaxel—kidney cancer	0.00015	0.000733	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—kidney cancer	0.000149	0.00073	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—kidney cancer	0.000146	0.000715	CcSEcCtD
Dinoprostone—Hypersensitivity—Capecitabine—kidney cancer	0.000145	0.000708	CcSEcCtD
Dinoprostone—Nausea—Paclitaxel—kidney cancer	0.000142	0.000695	CcSEcCtD
Dinoprostone—Asthenia—Capecitabine—kidney cancer	0.000141	0.000689	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—kidney cancer	0.000139	0.00068	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—kidney cancer	0.000137	0.000667	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—kidney cancer	0.000136	0.000662	CcSEcCtD
Dinoprostone—Diarrhoea—Capecitabine—kidney cancer	0.000135	0.000657	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—kidney cancer	0.000134	0.000655	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—kidney cancer	0.000132	0.000646	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—kidney cancer	0.000132	0.000646	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—kidney cancer	0.000132	0.000646	CcSEcCtD
Dinoprostone—Dizziness—Capecitabine—kidney cancer	0.00013	0.000635	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000127	0.000619	CcSEcCtD
Dinoprostone—Vomiting—Capecitabine—kidney cancer	0.000125	0.000611	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—kidney cancer	0.000125	0.000609	CcSEcCtD
Dinoprostone—Rash—Capecitabine—kidney cancer	0.000124	0.000606	CcSEcCtD
Dinoprostone—Dermatitis—Capecitabine—kidney cancer	0.000124	0.000605	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—kidney cancer	0.000124	0.000604	CcSEcCtD
Dinoprostone—Headache—Capecitabine—kidney cancer	0.000123	0.000602	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000123	0.000599	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—kidney cancer	0.000119	0.000579	CcSEcCtD
Dinoprostone—Nausea—Capecitabine—kidney cancer	0.000117	0.000571	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000116	0.000564	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—kidney cancer	0.000114	0.000556	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—kidney cancer	0.000113	0.000552	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—kidney cancer	0.000108	0.00053	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000104	0.000506	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—kidney cancer	0.0001	0.00049	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—kidney cancer	0.0001	0.00049	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—kidney cancer	9.35e-05	0.000456	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—kidney cancer	9.1e-05	0.000444	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—kidney cancer	8.68e-05	0.000424	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—kidney cancer	8.39e-05	0.00041	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—kidney cancer	8.07e-05	0.000394	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—kidney cancer	8e-05	0.00039	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—kidney cancer	7.99e-05	0.00039	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—kidney cancer	7.95e-05	0.000388	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—kidney cancer	7.53e-05	0.000368	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—ERBB2—kidney cancer	1.52e-05	8.41e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—kidney cancer	1.5e-05	8.33e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—SLC2A1—kidney cancer	1.5e-05	8.31e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MTOR—kidney cancer	1.5e-05	8.3e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL2—kidney cancer	1.49e-05	8.26e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—BCHE—kidney cancer	1.49e-05	8.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.49e-05	8.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SCARB1—kidney cancer	1.48e-05	8.21e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—MAPK1—kidney cancer	1.47e-05	8.17e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.47e-05	8.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.47e-05	8.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPAT—kidney cancer	1.47e-05	8.14e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS1—kidney cancer	1.47e-05	8.12e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—APC—kidney cancer	1.46e-05	8.1e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KIT—kidney cancer	1.46e-05	8.1e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MAPK3—kidney cancer	1.46e-05	8.08e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTT1—kidney cancer	1.46e-05	8.08e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ACHE—kidney cancer	1.46e-05	8.08e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.45e-05	8.06e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCND1—kidney cancer	1.45e-05	8.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.45e-05	8.04e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—JUN—kidney cancer	1.45e-05	8.03e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CTNNB1—kidney cancer	1.44e-05	7.97e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PSMD7—kidney cancer	1.44e-05	7.97e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.44e-05	7.95e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KIT—kidney cancer	1.43e-05	7.92e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—APC—kidney cancer	1.43e-05	7.92e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—APC—kidney cancer	1.43e-05	7.92e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KIT—kidney cancer	1.43e-05	7.92e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—MAPK3—kidney cancer	1.42e-05	7.88e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.42e-05	7.86e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—kidney cancer	1.42e-05	7.86e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN1B—kidney cancer	1.4e-05	7.79e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.4e-05	7.78e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PTEN—kidney cancer	1.4e-05	7.77e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—POMC—kidney cancer	1.4e-05	7.76e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—MAPK3—kidney cancer	1.4e-05	7.75e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—POMC—kidney cancer	1.39e-05	7.71e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MAPK1—kidney cancer	1.39e-05	7.69e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTP1—kidney cancer	1.38e-05	7.67e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SCARB1—kidney cancer	1.38e-05	7.65e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—RAF1—kidney cancer	1.38e-05	7.64e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.38e-05	7.63e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL2—kidney cancer	1.37e-05	7.62e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—BRAF—kidney cancer	1.37e-05	7.61e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—MAPK3—kidney cancer	1.37e-05	7.59e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—MAPK3—kidney cancer	1.37e-05	7.59e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS1—kidney cancer	1.37e-05	7.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APRT—kidney cancer	1.37e-05	7.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FH—kidney cancer	1.37e-05	7.57e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB2—kidney cancer	1.36e-05	7.56e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—BCHE—kidney cancer	1.36e-05	7.55e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—POMC—kidney cancer	1.36e-05	7.54e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—POMC—kidney cancer	1.36e-05	7.54e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—MAPK1—kidney cancer	1.35e-05	7.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.35e-05	7.5e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.35e-05	7.49e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SLC5A5—kidney cancer	1.35e-05	7.46e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MTOR—kidney cancer	1.35e-05	7.46e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—BRAF—kidney cancer	1.34e-05	7.45e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—BRAF—kidney cancer	1.34e-05	7.45e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CD4—kidney cancer	1.34e-05	7.44e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCND1—kidney cancer	1.34e-05	7.43e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PSMD7—kidney cancer	1.34e-05	7.42e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—JUN—kidney cancer	1.34e-05	7.41e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.33e-05	7.39e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—kidney cancer	1.33e-05	7.39e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—MAPK1—kidney cancer	1.33e-05	7.38e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CTNNB1—kidney cancer	1.33e-05	7.36e-05	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PIK3CA—kidney cancer	1.33e-05	7.35e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KRAS—kidney cancer	1.31e-05	7.26e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.31e-05	7.26e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—MAPK1—kidney cancer	1.3e-05	7.22e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—MAPK1—kidney cancer	1.3e-05	7.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.3e-05	7.2e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PTEN—kidney cancer	1.29e-05	7.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPC3—kidney cancer	1.28e-05	7.11e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—KRAS—kidney cancer	1.28e-05	7.08e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—PIK3CA—kidney cancer	1.27e-05	7.05e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.27e-05	7.05e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—BCHE—kidney cancer	1.27e-05	7.04e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.27e-05	7.03e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—kidney cancer	1.27e-05	7.02e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1B—kidney cancer	1.26e-05	7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—KRAS—kidney cancer	1.26e-05	6.97e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SLC5A5—kidney cancer	1.25e-05	6.95e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTP1—kidney cancer	1.25e-05	6.93e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CA2—kidney cancer	1.25e-05	6.92e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—PIK3CA—kidney cancer	1.25e-05	6.9e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—PIK3CA—kidney cancer	1.25e-05	6.9e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.24e-05	6.87e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—KRAS—kidney cancer	1.23e-05	6.82e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KRAS—kidney cancer	1.23e-05	6.82e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—POMC—kidney cancer	1.23e-05	6.79e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALAD—kidney cancer	1.22e-05	6.74e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SLC2A1—kidney cancer	1.21e-05	6.71e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.21e-05	6.68e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PIK3CA—kidney cancer	1.2e-05	6.67e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.2e-05	6.65e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK3—kidney cancer	1.2e-05	6.64e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CTNNB1—kidney cancer	1.19e-05	6.61e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.19e-05	6.58e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ABCB1—kidney cancer	1.18e-05	6.56e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.18e-05	6.56e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.17e-05	6.51e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—kidney cancer	1.17e-05	6.48e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—kidney cancer	1.16e-05	6.46e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—kidney cancer	1.16e-05	6.46e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTEN—kidney cancer	1.16e-05	6.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.16e-05	6.43e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.16e-05	6.4e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PIK3CA—kidney cancer	1.16e-05	6.4e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTM1—kidney cancer	1.15e-05	6.37e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RAF1—kidney cancer	1.15e-05	6.35e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RELA—kidney cancer	1.14e-05	6.33e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK1—kidney cancer	1.14e-05	6.32e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—kidney cancer	1.14e-05	6.3e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—kidney cancer	1.13e-05	6.29e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PIK3CA—kidney cancer	1.13e-05	6.27e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PIK3CA—kidney cancer	1.13e-05	6.27e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RAF1—kidney cancer	1.12e-05	6.22e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RAF1—kidney cancer	1.12e-05	6.22e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.12e-05	6.21e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MTOR—kidney cancer	1.12e-05	6.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RELA—kidney cancer	1.12e-05	6.19e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RELA—kidney cancer	1.12e-05	6.19e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—kidney cancer	1.12e-05	6.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PGK1—kidney cancer	1.11e-05	6.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.11e-05	6.17e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—kidney cancer	1.11e-05	6.15e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—kidney cancer	1.11e-05	6.15e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK3—kidney cancer	1.11e-05	6.13e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MTOR—kidney cancer	1.1e-05	6.07e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MTOR—kidney cancer	1.1e-05	6.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LDHB—kidney cancer	1.09e-05	6.05e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP1A1—kidney cancer	1.09e-05	6.04e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.09e-05	6.03e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTP1—kidney cancer	1.08e-05	6.01e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—kidney cancer	1.08e-05	5.96e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—kidney cancer	1.07e-05	5.96e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK1—kidney cancer	1.05e-05	5.83e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1B—kidney cancer	1.05e-05	5.82e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.03e-05	5.71e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1B—kidney cancer	1.03e-05	5.7e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1B—kidney cancer	1.03e-05	5.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—kidney cancer	1.03e-05	5.7e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCB1—kidney cancer	1.03e-05	5.69e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—kidney cancer	1.01e-05	5.6e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—kidney cancer	1.01e-05	5.58e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—kidney cancer	1.01e-05	5.58e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—kidney cancer	1e-05	5.55e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—kidney cancer	1e-05	5.54e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—kidney cancer	9.96e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—kidney cancer	9.93e-06	5.51e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—kidney cancer	9.93e-06	5.5e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—kidney cancer	9.92e-06	5.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.9e-06	5.49e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—kidney cancer	9.89e-06	5.48e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—kidney cancer	9.81e-06	5.44e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—kidney cancer	9.81e-06	5.44e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—kidney cancer	9.79e-06	5.42e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—kidney cancer	9.79e-06	5.42e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—kidney cancer	9.78e-06	5.42e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTEN—kidney cancer	9.74e-06	5.4e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—kidney cancer	9.71e-06	5.38e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—kidney cancer	9.71e-06	5.38e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTEN—kidney cancer	9.67e-06	5.36e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—kidney cancer	9.66e-06	5.35e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—kidney cancer	9.57e-06	5.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—kidney cancer	9.57e-06	5.3e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTEN—kidney cancer	9.47e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTEN—kidney cancer	9.47e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CA9—kidney cancer	9.46e-06	5.24e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK1—kidney cancer	9.45e-06	5.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP1A1—kidney cancer	9.44e-06	5.23e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—kidney cancer	9.29e-06	5.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.25e-06	5.13e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—kidney cancer	9.13e-06	5.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—POMC—kidney cancer	8.99e-06	4.98e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.95e-06	4.96e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—kidney cancer	8.93e-06	4.95e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—kidney cancer	8.83e-06	4.89e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1A1—kidney cancer	8.8e-06	4.88e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—kidney cancer	8.74e-06	4.84e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—kidney cancer	8.55e-06	4.74e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—kidney cancer	8.55e-06	4.74e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTEN—kidney cancer	8.53e-06	4.73e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.47e-06	4.69e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—kidney cancer	8.26e-06	4.58e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—kidney cancer	8.2e-06	4.55e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—POMC—kidney cancer	8.12e-06	4.5e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—kidney cancer	8.09e-06	4.48e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—kidney cancer	8.09e-06	4.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CRABP1—kidney cancer	8.05e-06	4.46e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—kidney cancer	8.04e-06	4.45e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—kidney cancer	7.87e-06	4.36e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—kidney cancer	7.87e-06	4.36e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK1—kidney cancer	7.86e-06	4.36e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK1—kidney cancer	7.7e-06	4.27e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK1—kidney cancer	7.7e-06	4.27e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—POMC—kidney cancer	7.68e-06	4.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ITPR2—kidney cancer	7.48e-06	4.15e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—kidney cancer	7.43e-06	4.12e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—kidney cancer	7.27e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—kidney cancer	7.27e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—kidney cancer	7.17e-06	3.97e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—POMC—kidney cancer	7.04e-06	3.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.9e-06	3.82e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—kidney cancer	6.87e-06	3.81e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—kidney cancer	6.82e-06	3.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACHE—kidney cancer	6.82e-06	3.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTT1—kidney cancer	6.82e-06	3.78e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—kidney cancer	6.68e-06	3.7e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—kidney cancer	6.68e-06	3.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—kidney cancer	6.6e-06	3.66e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—POMC—kidney cancer	6.56e-06	3.64e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—kidney cancer	6.48e-06	3.59e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—kidney cancer	6.46e-06	3.58e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—kidney cancer	6.46e-06	3.58e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SCARB1—kidney cancer	6.46e-06	3.58e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS1—kidney cancer	6.39e-06	3.54e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PSMD7—kidney cancer	6.27e-06	3.47e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTEN—kidney cancer	6.25e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—kidney cancer	6.13e-06	3.4e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—kidney cancer	6.02e-06	3.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BCHE—kidney cancer	5.94e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.87e-06	3.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.67e-06	3.14e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTEN—kidney cancer	5.65e-06	3.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—kidney cancer	5.62e-06	3.11e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.5e-06	3.05e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTEN—kidney cancer	5.35e-06	2.96e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—kidney cancer	5.24e-06	2.9e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTEN—kidney cancer	4.9e-06	2.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.8e-06	2.66e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—kidney cancer	4.73e-06	2.62e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTEN—kidney cancer	4.57e-06	2.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—kidney cancer	4.48e-06	2.48e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—kidney cancer	4.41e-06	2.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—kidney cancer	4.34e-06	2.41e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.12e-06	2.28e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—kidney cancer	3.99e-06	2.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.77e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—kidney cancer	3.46e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.38e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—kidney cancer	3.22e-06	1.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POMC—kidney cancer	3.07e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—kidney cancer	2.45e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTEN—kidney cancer	2.14e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.51e-06	8.35e-06	CbGpPWpGaD
